The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

VI.b

Pulmonary arterial hypertension

Publications

Kolaitis NA, Saggar R, De Marco T

Methamphetamine-associated pulmonary arterial hypertension.

Current opinion in pulmonary medicine. 2022;28(5):352-360

Ramirez RL 3rd, Perez VJ, Zamanian RT

Methamphetamine and the risk of pulmonary arterial hypertension.

Current opinion in pulmonary medicine. 2018;24(5):416-424

de Jesus Perez V, Kudelko K, Snook S, Zamanian RT

Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead.

International journal of clinical practice. Supplement. 2011:8-10

Thompson CA

Pulmonary arterial hypertension seen in methamphetamine abusers.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2008;65(12):1109-10

Chin KM, Channick RN, Rubin LJ

Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?

Chest. 2006;130(6):1657-63

Albertson TE, Derlet RW, Van Hoozen BE

Methamphetamine and the expanding complications of amphetamines.

The Western journal of medicine. 1999;170(4):214-9

Schaiberger PH, Kennedy TC, Miller FC, Gal J, Petty TL

Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine.

Chest. 1993;104(2):614-6